RNA Nanotherapeutics
PrivateLast Round
Grant
Oct 13, 2025
Total Funding Raised
$400,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RNA Nanotherapeutics is a biotechnology company that develops cancer-targeting multifunctional RNA nanoparticles designed to improve therapeutic efficacy and reduce side effects in cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNA Nanotherapeutics Comparables
Compare RNA Nanotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sixfold Bioscience | 88% | |
| RNA NanoBiotics, Inc. | 86% | |
| Kernal Biologics | 77% | |
RNA Nanotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 13, 2025 | ||||
| Grant | Jul 31, 2025 | ||||
| Grant | Oct 7, 2022 |
RNA Nanotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ohio Third Frontier | Grant |
| University of Cincinnati Venture Lab | Accelerator |
| Ohio's Entrepreneurial Services Provider Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 76% MoM, reaching 1K.
- Oct 13, 2025
$200K raised from Ohio Third Frontier.
RNA Nanotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RNA Nanotherapeutics's valuation, stock price, and market status.